Does CANRENOATE Cause Therapy non-responder? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Therapy non-responder have been filed in association with CANRENOATE. This represents 1.1% of all adverse event reports for CANRENOATE.
5
Reports of Therapy non-responder with CANRENOATE
1.1%
of all CANRENOATE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Therapy non-responder From CANRENOATE?
Of the 5 reports, 2 (40.0%) required hospitalization.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANRENOATE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CANRENOATE Cause?
Hyperkalaemia (96)
Acute kidney injury (63)
Toxic epidermal necrolysis (58)
Hyponatraemia (52)
Off label use (45)
Dehydration (39)
Hypotension (39)
Drug hypersensitivity (37)
Dyspnoea (36)
Asthenia (33)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which CANRENOATE Alternatives Have Lower Therapy non-responder Risk?
CANRENOATE vs CANRENOIC ACID
CANRENOATE vs CANRENONE
CANRENOATE vs CANTHARIDIN
CANRENOATE vs CAPECITABINE
CANRENOATE vs CAPIVASERTIB